Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing

Colorectal adenomas are precursor lesions of colorectal adenocarcinoma. The transition from adenoma to carcinoma in patients with colorectal cancer (CRC) has been associated with an accumulation of genetic aberrations. However, criteria that can screen adenoma progression to adenocarcinoma are still...

Full description

Bibliographic Details
Main Authors: Thoranin Intarajak, Wandee Udomchaiprasertkul, Chakrit Bunyoo, Jutamas Yimnoon, Kamonwan Soonklang, Kriangpol Wiriyaukaradecha, Wisut Lamlertthon, Thaniya Sricharunrat, Worawit Chaiwiriyawong, Bunchorn Siriphongpreeda, Sawannee Sutheeworapong, Kanthida Kusonmano, Weerayuth Kittichotirat, Chinae Thammarongtham, Piroon Jenjaroenpun, Thidathip Wongsurawat, Intawat Nookaew, Chirayu Auewarakul, Supapon Cheevadhanarak
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/7/977
id doaj-d1e2948a24504347805ec3cf0db7af37
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Thoranin Intarajak
Wandee Udomchaiprasertkul
Chakrit Bunyoo
Jutamas Yimnoon
Kamonwan Soonklang
Kriangpol Wiriyaukaradecha
Wisut Lamlertthon
Thaniya Sricharunrat
Worawit Chaiwiriyawong
Bunchorn Siriphongpreeda
Sawannee Sutheeworapong
Kanthida Kusonmano
Weerayuth Kittichotirat
Chinae Thammarongtham
Piroon Jenjaroenpun
Thidathip Wongsurawat
Intawat Nookaew
Chirayu Auewarakul
Supapon Cheevadhanarak
spellingShingle Thoranin Intarajak
Wandee Udomchaiprasertkul
Chakrit Bunyoo
Jutamas Yimnoon
Kamonwan Soonklang
Kriangpol Wiriyaukaradecha
Wisut Lamlertthon
Thaniya Sricharunrat
Worawit Chaiwiriyawong
Bunchorn Siriphongpreeda
Sawannee Sutheeworapong
Kanthida Kusonmano
Weerayuth Kittichotirat
Chinae Thammarongtham
Piroon Jenjaroenpun
Thidathip Wongsurawat
Intawat Nookaew
Chirayu Auewarakul
Supapon Cheevadhanarak
Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing
Cancers
somatic mutation
colorectal adenoma
early-stage colorectal adenocarcinoma
screen marker
author_facet Thoranin Intarajak
Wandee Udomchaiprasertkul
Chakrit Bunyoo
Jutamas Yimnoon
Kamonwan Soonklang
Kriangpol Wiriyaukaradecha
Wisut Lamlertthon
Thaniya Sricharunrat
Worawit Chaiwiriyawong
Bunchorn Siriphongpreeda
Sawannee Sutheeworapong
Kanthida Kusonmano
Weerayuth Kittichotirat
Chinae Thammarongtham
Piroon Jenjaroenpun
Thidathip Wongsurawat
Intawat Nookaew
Chirayu Auewarakul
Supapon Cheevadhanarak
author_sort Thoranin Intarajak
title Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing
title_short Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing
title_full Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing
title_fullStr Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing
title_full_unstemmed Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing
title_sort genetic aberration analysis in thai colorectal adenoma and early-stage adenocarcinoma patients by whole-exome sequencing
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2019-07-01
description Colorectal adenomas are precursor lesions of colorectal adenocarcinoma. The transition from adenoma to carcinoma in patients with colorectal cancer (CRC) has been associated with an accumulation of genetic aberrations. However, criteria that can screen adenoma progression to adenocarcinoma are still lacking. This present study is the first attempt to identify genetic aberrations, such as the somatic mutations, copy number variations (CNVs), and high-frequency mutated genes, found in Thai patients. In this study, we identified the genomic abnormality of two sample groups. In the first group, five cases matched normal-colorectal adenoma-colorectal adenocarcinoma. In the second group, six cases matched normal-colorectal adenomas. For both groups, whole-exome sequencing was performed. We compared the genetic aberration of the two sample groups. In both normal tissues compared with colorectal adenoma and colorectal adenocarcinoma analyses, somatic mutations were observed in the tumor suppressor gene <i>APC</i> (Adenomatous polyposis coli) in eight out of ten patients. In the group of normal tissue comparison with colorectal adenoma tissue, somatic mutations were also detected in Catenin Beta 1 (<i>CTNNB1</i>), Family With Sequence Similarity 123B (<i>FAM123B</i>), F-Box And WD Repeat Domain Containing 7 (<i>FBXW7</i>), Sex-Determining Region Y-Box 9 (<i>SOX9</i>), Low-Density Lipoprotein Receptor-Related Protein 5 (<i>LRP5</i>), Frizzled Class Receptor 10 (<i>FZD10</i>), and AT-Rich Interaction Domain 1A (<i>ARID1A</i>) genes, which are involved in the Wingless-related integration site (Wnt) signaling pathway. In the normal tissue comparison with colorectal adenocarcinoma tissue, Kirsten retrovirus-associated DNA sequences (<i>KRAS</i>), Tumor Protein 53 (<i>TP53</i>), and Ataxia-Telangiectasia Mutated (<i>ATM</i>) genes are found in the receptor tyrosine kinase-RAS (RTK–RAS) signaling pathway and p53 signaling pathway, respectively. These results suggest that <i>APC</i> and <i>TP53</i> may act as a potential screening marker for colorectal adenoma and early-stage CRC. This preliminary study may help identify patients with adenoma and early-stage CRC and may aid in establishing prevention and surveillance strategies to reduce the incidence of CRC.
topic somatic mutation
colorectal adenoma
early-stage colorectal adenocarcinoma
screen marker
url https://www.mdpi.com/2072-6694/11/7/977
work_keys_str_mv AT thoraninintarajak geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT wandeeudomchaiprasertkul geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT chakritbunyoo geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT jutamasyimnoon geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT kamonwansoonklang geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT kriangpolwiriyaukaradecha geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT wisutlamlertthon geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT thaniyasricharunrat geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT worawitchaiwiriyawong geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT bunchornsiriphongpreeda geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT sawanneesutheeworapong geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT kanthidakusonmano geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT weerayuthkittichotirat geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT chinaethammarongtham geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT piroonjenjaroenpun geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT thidathipwongsurawat geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT intawatnookaew geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT chirayuauewarakul geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
AT supaponcheevadhanarak geneticaberrationanalysisinthaicolorectaladenomaandearlystageadenocarcinomapatientsbywholeexomesequencing
_version_ 1725864453529927680
spelling doaj-d1e2948a24504347805ec3cf0db7af372020-11-24T21:54:59ZengMDPI AGCancers2072-66942019-07-0111797710.3390/cancers11070977cancers11070977Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome SequencingThoranin Intarajak0Wandee Udomchaiprasertkul1Chakrit Bunyoo2Jutamas Yimnoon3Kamonwan Soonklang4Kriangpol Wiriyaukaradecha5Wisut Lamlertthon6Thaniya Sricharunrat7Worawit Chaiwiriyawong8Bunchorn Siriphongpreeda9Sawannee Sutheeworapong10Kanthida Kusonmano11Weerayuth Kittichotirat12Chinae Thammarongtham13Piroon Jenjaroenpun14Thidathip Wongsurawat15Intawat Nookaew16Chirayu Auewarakul17Supapon Cheevadhanarak18Bioinformatics and Systems Biology Program, School of Bioresources and Technology and School of Information Technology, King Mongkut’s University of Technology Thonburi, Bangkok 10150, ThailandMolecular Biology and Genomic Laboratory, Division of Research and International Relations, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, ThailandBioinformatics Unit for Genomic Analysis, Division of Research and International Relations, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, ThailandCytogenetics Unit, Central Research Laboratory, Division of Research and International Relations, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, ThailandData Management Unit, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, ThailandMolecular Biology and Genomic Laboratory, Division of Research and International Relations, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, ThailandFaculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, ThailandPathology Laboratory Unit, Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, ThailandDepartment of Medical Oncology, Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, ThailandFaculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, ThailandBioinformatics and Systems Biology Program, School of Bioresources and Technology and School of Information Technology, King Mongkut’s University of Technology Thonburi, Bangkok 10150, ThailandBioinformatics and Systems Biology Program, School of Bioresources and Technology and School of Information Technology, King Mongkut’s University of Technology Thonburi, Bangkok 10150, ThailandBioinformatics and Systems Biology Program, School of Bioresources and Technology and School of Information Technology, King Mongkut’s University of Technology Thonburi, Bangkok 10150, ThailandBiochemical Engineering and Systems Biology research group, National Center for Genetic Engineering and Biotechnology (BIOTEC) at King Mongkut’s University of Technology Thonburi, Bangkhuntien, Bangkok 10150, ThailandDepartment of Biomedical Informatics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USADepartment of Biomedical Informatics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USADepartment of Biomedical Informatics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USAFaculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, ThailandSystems Biology and Bioinformatics Research Group, Pilot Plant Development and Training Institute, King Mongkut’s University of Technology Thonburi, Bangkok 10150, ThailandColorectal adenomas are precursor lesions of colorectal adenocarcinoma. The transition from adenoma to carcinoma in patients with colorectal cancer (CRC) has been associated with an accumulation of genetic aberrations. However, criteria that can screen adenoma progression to adenocarcinoma are still lacking. This present study is the first attempt to identify genetic aberrations, such as the somatic mutations, copy number variations (CNVs), and high-frequency mutated genes, found in Thai patients. In this study, we identified the genomic abnormality of two sample groups. In the first group, five cases matched normal-colorectal adenoma-colorectal adenocarcinoma. In the second group, six cases matched normal-colorectal adenomas. For both groups, whole-exome sequencing was performed. We compared the genetic aberration of the two sample groups. In both normal tissues compared with colorectal adenoma and colorectal adenocarcinoma analyses, somatic mutations were observed in the tumor suppressor gene <i>APC</i> (Adenomatous polyposis coli) in eight out of ten patients. In the group of normal tissue comparison with colorectal adenoma tissue, somatic mutations were also detected in Catenin Beta 1 (<i>CTNNB1</i>), Family With Sequence Similarity 123B (<i>FAM123B</i>), F-Box And WD Repeat Domain Containing 7 (<i>FBXW7</i>), Sex-Determining Region Y-Box 9 (<i>SOX9</i>), Low-Density Lipoprotein Receptor-Related Protein 5 (<i>LRP5</i>), Frizzled Class Receptor 10 (<i>FZD10</i>), and AT-Rich Interaction Domain 1A (<i>ARID1A</i>) genes, which are involved in the Wingless-related integration site (Wnt) signaling pathway. In the normal tissue comparison with colorectal adenocarcinoma tissue, Kirsten retrovirus-associated DNA sequences (<i>KRAS</i>), Tumor Protein 53 (<i>TP53</i>), and Ataxia-Telangiectasia Mutated (<i>ATM</i>) genes are found in the receptor tyrosine kinase-RAS (RTK–RAS) signaling pathway and p53 signaling pathway, respectively. These results suggest that <i>APC</i> and <i>TP53</i> may act as a potential screening marker for colorectal adenoma and early-stage CRC. This preliminary study may help identify patients with adenoma and early-stage CRC and may aid in establishing prevention and surveillance strategies to reduce the incidence of CRC.https://www.mdpi.com/2072-6694/11/7/977somatic mutationcolorectal adenomaearly-stage colorectal adenocarcinomascreen marker